Invention Grant
- Patent Title: Spiro-oxindole compounds and their use as therapeutic agents
- Patent Title (中): 螺 - 羟吲哚化合物及其作为治疗剂的用途
-
Application No.: US14542367Application Date: 2014-11-14
-
Publication No.: US09458178B2Publication Date: 2016-10-04
- Inventor: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Yurevna Zenova , Qi Jia , Jean-Jacques Alexandre Cadieux , Simon J. Gauthier , Amy Frances Douglas , Tom Hsieh , Nagasree Chakka , Zoran Cikojevic
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Agency: Seed IP Law Group PLLC
- Main IPC: C07D513/20
- IPC: C07D513/20 ; C07D491/10 ; C07D491/107 ; C07D491/20 ; C07D491/22 ; C07D495/20 ; C07D498/20 ; C07D519/00
Abstract:
This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Public/Granted literature
- US20150291623A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Public/Granted day:2015-10-15
Information query
